Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies — Pamela J Bjorkman (CALIFORNIA INSTITUTE OF TECHNOLOGY
PROJECT SUMMARY A central goal in HIV/AIDS vaccine research is the elicitation of broadly neutralizing antibodies (bNAbs). During the previous funding period, the Bjorkman lab used novel design strate
| Project title | Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies |
|---|---|
| Project number | 2P01AI100148-11 |
| PI name | Pamela J Bjorkman |
| Institution | CALIFORNIA INSTITUTE OF TECHNOLOGY |
| Funding mechanism | P01 |
| Agency | NIAID |
| Award amount | $4.20M |
| Fiscal year | 2024 |
| Project start | 2013-02-10T00:00:00 |
| Project end | 2028-12-31T00:00:00 |
| Abstract | PROJECT SUMMARY A central goal in HIV/AIDS vaccine research is the elicitation of broadly neutralizing antibodies (bNAbs). During the previous funding period, the Bjorkman lab used novel design strate |
| Key terms | <AIDS><AIDS/HIV><Acquired Immune Deficiency><Acquired Immune Deficiency Syndrome><Acquired Immunodef |
$799/mo
Try GrantRadar →